Related Experiment Video
Updated: Feb 18, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Approach to Chronic Secondary Headache: A Case Report on Unusual Drug Side Effects
Hamid Reza Riasi1, Forod Salehi2, Morteza Hajihosseini3
1Department of Neurology, Birjand University of Medical Sciences, Birjand, Iran.
Insights
Growth hormone (GH) use may cause increased intracranial pressure in children. Regular ophthalmoscopy is crucial for monitoring patients on GH therapy to detect potential risks early.
Area of Science:
- Pediatric Endocrinology
- Neuro-Ophthalmology
Background:
- Growth hormone (GH) therapy is widely used in pediatric endocrinology.
- Increased intracranial pressure (ICP) can lead to serious neurological complications.
Observation:
- A 12-year-old female presented with chronic headache, nausea, vomiting, and papilledema.
- Neurological examination revealed a sixth cranial nerve palsy.
- Brain MRI was unremarkable, but lumbar puncture showed elevated cerebrospinal fluid (CSF) pressure (280 mmH2O).
Findings:
- The patient had a history of 2 years of growth hormone (GH) use.
- Symptoms resolved after repeated lumbar punctures and discontinuation of GH.
- No relapse was observed 6 months post-discontinuation, suggesting GH as a potential cause of pseudotumor cerebri.
Implications:
- Growth hormone therapy should be considered a potential etiological factor for increased intracranial pressure in children.
- Ophthalmoscopy should be a routine part of follow-up for all children receiving GH therapy.
- This case highlights the importance of vigilant monitoring for neuro-ophthalmic side effects during GH treatment.
Abstract:
In this article, we present the case of a 12-year-old female child who complained of bilateral temporal and frontal headache for 2 to 3 months with nausea and vomiting. Physical examination revealed right-sided sixth cranial nerve palsy and papilledema in ophthalmoscopy. To find the cause of increased intracranial pressure, the patient underwent brain imaging and brain MRI showed no abnormality. Ultimately, lumbar puncture (LP) was performed and cerebrospinal fluid (CSF) pressure was 280 mmH2O with normal chemistry. We considered pseudotumor cerebri as the first diagnosis. LP was carried out three times and 30cc of CSF was tapped each time. Finally, patient's headache and papilledema improved and physical examination after 6 months showed no sign of raised intracranial pressure (rICP). The most prominent point in her past medical history was the use of growth hormone (GH) for 2 years. No sign of symptom relapse has been seen after 6 months of drug discontinuation. We must consider the hazard of growth hormone as a potential cause of increased intracranial pressure. When the use of GH is justified, the follow-up must include an ophthalmoscopy examination in each session.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Therapy
Antianxiety Medications
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Toxicity: Dose-Dependent Reactions
Psychosis: Goals of Pharmacotherapy

